Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ProFrac A | ACDC | Nov 27, 2024 | 9.13 | +8.18 |
PROG | PRG | Nov 27, 2024 | 48.21 | -1.89 |
Progress Software | PRGS | Nov 27, 2024 | 67.56 | -2.99 |
Progressive | PGR | Nov 27, 2024 | 266.86 | -0.43 |
Progyny | PGNY | Nov 27, 2024 | 15.48 | +1.38 |
ProKidney | PROK | Nov 27, 2024 | 1.85 | -1.60 |
Prologis | PLD | Nov 27, 2024 | 117.80 | +1.40 |
ProMIS Neurosciences | PMN | Nov 27, 2024 | 0.94 | +2.17 |
PropertyGuru | PGRU | Nov 27, 2024 | 6.65 | 0.00 |
ProPetro | PUMP | Nov 27, 2024 | 8.48 | +0.83 |
ProPhase Labs | PRPH | Nov 27, 2024 | 0.77 | +2.80 |
ProQR Therapeutics | PRQR | Nov 27, 2024 | 3.67 | +6.69 |
PROS | PRO | Nov 27, 2024 | 23.27 | +1.17 |
ProShares Bitcoin Strategy ETF | BITO | Nov 27, 2024 | 25.99 | +6.52 |
Proshares Ultra FTSE Europe | UPV | Nov 27, 2024 | 57.50 | +1.49 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | Nov 27, 2024 | 64.59 | +17.10 |
Proshares Ultrashort FTSE Europe | EPV | Nov 27, 2024 | 40.19 | -3.02 |
Prospect Capital | PSEC | Nov 27, 2024 | 4.75 | +0.21 |
Prospect Capital A Pref | PSEC-A | Nov 27, 2024 | 19.30 | -0.05 |
Prosperity Bancshares | PB | Nov 27, 2024 | 84.17 | -0.66 |
Protagenic Therapeutics | PTIX | Nov 27, 2024 | 0.60 | -18.08 |
Protagonist Therapeutics | PTGX | Nov 27, 2024 | 44.95 | +0.27 |
Protalix Bio Therapeutics | PLX | Nov 27, 2024 | 1.69 | +0.60 |
Protara Therapeutics | TARA | Nov 27, 2024 | 3.04 | +3.40 |
Prothena | PRTA | Nov 27, 2024 | 15.88 | +1.93 |
Proto Labs | PRLB | Nov 27, 2024 | 40.80 | -0.75 |
Provident Bancorp | PVBC | Nov 27, 2024 | 11.48 | -0.86 |
Provident Financial | PROV | Nov 27, 2024 | 15.95 | -0.44 |
Provident Financial Services | PFS | Nov 27, 2024 | 21.33 | +0.19 |
Prudential ADR | PUK | Nov 27, 2024 | 16.33 | +1.43 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.